With the evolution of medicine and science in the days of today, very recently researchers at the University of Adelaide have developed a treatment for cancer of theThebreast with immediate implications. The study was carried out in collaboration with the Garvan Institute for Medical Research which examined the role of andrThegIt isnios - popularly known as hormonas masculine sexualThes, but also found at lower levels in women - as a potential treatment for cancerThe breast, estrogen receptor positive.

At the normal development mammary, estrogen stimulates and the andrThegIt isnio inhibits growth npuberty and throughout adult life. THE not normal estrogen activity is responsible for most d cancersThe breast, but the role of andr activityThegIt isnithose in this disease have been controversial.

THEs andrThegIt isnithe were historically used to treat cancerThe breast but knowledge dand hormone receptors in breast tissue was rudimentary at the time and The efficiencyFrom treatments misunderstood. Andro therapygIt isnica was discontinued due to side effects virilizesntes and with the arrival of endocrine anti-estrogenic therapies.

Researchers at the University of Adelaide and the Garvan Institute have demonstrated that the activation of the androgen receptor canr one natural androgen or per a new androgenic drug, had a potent anti-tumor activity in all breast cancers with positive estrogen receptors, even the most resistant to current treatment methods. In contrast, inhibitors of the androgen receptor had no effect.

Dr. Stephen Birrell, cancer specialistThe breast, pioneer in andrThegIt isniwomen's health is that was part of the team at the University of Adelaide, referred that this discovery seminal has a use for beyond cancer treatment breast, including prevention breast cancer and the treatment of other disorders also driven by estrogen.

This study helpsfrog patients to hope that there is another answer to life after cancer diagnosis.